← Eichor
Study identifier: NCT05840575 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

Condition: Chemotherapy-Related Cognitive Impairment · Chemotherapeutic Toxicity · Chemo-brain  ·  Sponsor: Rigshospitalet, Denmark

PhaseN/A
Planned participants100
Who can joinAll sexes, 7 Years to 29 Years
Healthy volunteersYes

About this study

The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Lisa L Hjalgrim, PhD, MD  ·  +4535450962  ·  lisa.lyngsie.hjalgrim@regionh.dk

Barbara Nordhjem, PhD  ·  +4535457998  ·  barbara.johanne.thomas.nordhjem@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

RigshospitaletCopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05840575